Sanofi Pentacel Revised Action Date Is Nov. 2
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA extends the combination vaccine’s action date for the second time, this time requesting lab validation information relating to the pertussis component, but not directly related to Pentacel.
You may also be interested in...
Sanofi Pasteur’s Five-In-One Vaccine Approved
Next step for Pentacel is the June 25 ACIP Vaccines for Children vote.
Sanofi Pasteur’s Five-In-One Vaccine Approved
Next step for Pentacel is the June 25 ACIP Vaccines for Children vote.
Advisory Committee Recommends Sanofi’s Pentacel Combo Vaccine
Concerns regarding insufficient Haemophilus influenzae type b efficacy data are not great enough for committee members to withhold recommendation.